Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2007 1
2008 1
2012 2
2020 2
2021 2
2022 4
2023 3
2024 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16 results

Results by year

Filters applied: . Clear all
Page 1
Differences in IgG autoantibody Fab glycosylation across autoimmune diseases.
Koers J, Sciarrillo R, Derksen NIL, Vletter EM, Fillié-Grijpma YE, Raveling-Eelsing E, Graça NAG, Leijser T, Pas HH, Laura van Nijen-Vos L, Braham MVJ, Buisman AM, de Jong J, Schriek AI, Tio-Gillen AP, Teng YKO, Steenhuis M, Swaneveld FH, de Taeye SW, van Gils MJ, Verschuuren JJGM, Rutgers B, Heeringa P, Horváth B, Jacobs BC, de Leeuw K, Franssen CFM, Veyradier A, Coppo P, Gelderman KA, Marieke van Ham S, van Els CACM, van der Woude D, Huizinga R, Huijbers MG, Kuijpers TW, Toes REM, Bos NA, Rispens T; T2B Consortium. Koers J, et al. Among authors: swaneveld fh. J Allergy Clin Immunol. 2023 Jun;151(6):1646-1654. doi: 10.1016/j.jaci.2022.10.035. Epub 2023 Jan 27. J Allergy Clin Immunol. 2023. PMID: 36716825
Hyperimmune Globulin for Severely Immunocompromised Patients Hospitalized With Coronavirus Disease 2019: A Randomized, Controlled Trial.
Huygens S, Hofsink Q, Nijhof IS, Goorhuis A, Kater AP, Te Boekhorst PAW, Swaneveld F, Novotný VMJ, Bogers S, Welkers MRA, Papageorgiou G, Rijnders BJ, Heijmans J. Huygens S, et al. Among authors: swaneveld f. J Infect Dis. 2023 Jan 11;227(2):206-210. doi: 10.1093/infdis/jiac334. J Infect Dis. 2023. PMID: 35921542 Free PMC article. Clinical Trial.
Effects of Treatment of Coronavirus Disease 2019 With Convalescent Plasma in 25 B-Cell-Depleted Patients.
Gharbharan A, GeurtsvanKessel CH, Jordans CCE, Blaauw M, van der Klift M, Hassing RJ, Smits-Zwinkels M, Meertens M, van den Hout EC, de Man AM, Hageman I, Bogers S, van der Schoot CE, Swaneveld F, Anas AA, Rokx C, Rijnders BJA. Gharbharan A, et al. Among authors: swaneveld f. Clin Infect Dis. 2022 Apr 9;74(7):1271-1274. doi: 10.1093/cid/ciab647. Clin Infect Dis. 2022. PMID: 34293119 Free PMC article.
Author Correction: Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients.
Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageorgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho-Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García García V, Ruiz-Comellas A, Ramírez-Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, Rijnders BJA; CoV-Early study group; COnV-ert study group. Millat-Martinez P, et al. Among authors: swaneveld f. Nat Commun. 2024 May 22;15(1):4352. doi: 10.1038/s41467-024-48645-y. Nat Commun. 2024. PMID: 38778041 Free PMC article. No abstract available.
Associations Between Symptoms, Donor Characteristics and IgG Antibody Response in 2082 COVID-19 Convalescent Plasma Donors.
Vinkenoog M, Steenhuis M, Brinke AT, van Hasselt JGC, Janssen MP, van Leeuwen M, Swaneveld FH, Vrielink H, van de Watering L, Quee F, van den Hurk K, Rispens T, Hogema B, van der Schoot CE. Vinkenoog M, et al. Among authors: swaneveld fh. Front Immunol. 2022 Feb 28;13:821721. doi: 10.3389/fimmu.2022.821721. eCollection 2022. Front Immunol. 2022. PMID: 35296077 Free PMC article.
Dynamics of antibodies to SARS-CoV-2 in convalescent plasma donors.
Steenhuis M, van Mierlo G, Derksen NI, Ooijevaar-de Heer P, Kruithof S, Loeff FL, Berkhout LC, Linty F, Reusken C, Reimerink J, Hogema B, Zaaijer H, van de Watering L, Swaneveld F, van Gils MJ, Bosch BJ, van Ham SM, Ten Brinke A, Vidarsson G, van der Schoot EC, Rispens T. Steenhuis M, et al. Among authors: swaneveld f. Clin Transl Immunology. 2021 May 16;10(5):e1285. doi: 10.1002/cti2.1285. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34026115 Free PMC article.
Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients.
Millat-Martinez P, Gharbharan A, Alemany A, Rokx C, Geurtsvankessel C, Papageorgiou G, van Geloven N, Jordans C, Groeneveld G, Swaneveld F, van der Schoot E, Corbacho-Monné M, Ouchi D, Piccolo Ferreira F, Malchair P, Videla S, García García V, Ruiz-Comellas A, Ramírez-Morros A, Rodriguez Codina J, Amado Simon R, Grifols JR, Blanco J, Blanco I, Ara J, Bassat Q, Clotet B, Baro B, Troxel A, Zwaginga JJ, Mitjà O, Rijnders BJA; CoV-Early study group; COnV-ert study group. Millat-Martinez P, et al. Among authors: swaneveld f. Nat Commun. 2022 May 11;13(1):2583. doi: 10.1038/s41467-022-29911-3. Nat Commun. 2022. PMID: 35546145 Free PMC article.
Outpatient convalescent plasma therapy for high-risk patients with early COVID-19: a randomized placebo-controlled trial.
Gharbharan A, Jordans C, Zwaginga L, Papageorgiou G, van Geloven N, van Wijngaarden P, den Hollander J, Karim F, van Leeuwen-Segarceanu E, Soetekouw R, Lammers J, Postma D, Kampschreur L, Groeneveld G, Swaneveld F, van der Schoot CE, Götz H, Haagmans B, Koopmans M, Bogers S, Geurtsvankessel C, Zwaginga JJ, Rokx C, Rijnders B; CoV-Early study group. Gharbharan A, et al. Among authors: swaneveld f. Clin Microbiol Infect. 2023 Feb;29(2):208-214. doi: 10.1016/j.cmi.2022.08.005. Epub 2022 Aug 23. Clin Microbiol Infect. 2023. PMID: 36007870 Free PMC article. Clinical Trial.
16 results